Semaglutide is supplied for laboratory research workflows that require clear product identity, careful handling, and documented specifications.
Research use only. Not for human or veterinary consumption, diagnosis, or treatment.
Weight
0.05 lbs
Dimensions
4 × 3 × 2 in
📊 Research Dosages and Protocols
Research phase
Research dosage
Administration frequency
Starting / Adaptation
0.25 mg
Once weekly
Primary / Maintenance
0.5 - 1.0 mg
Once weekly
Maximum exposure
2.4 mg
Once weekly
* Note: The listed dosages are based on reference research models and should be adapted to the specific requirements of your laboratory protocol.
🧫 Reconstitution and Storage
Reconstitution: Bacteriostatic Water (BAC Water) is recommended. Add it slowly down the side of the vial. Gently swirl the vial without shaking aggressively.
Storage (lyophilized powder): Store in a dark place at -20°C to 4°C.
Storage (reconstituted): After reconstitution, refrigerate at 2°C to 8°C and use within 20–30 days.
🔬 Clinical Study Results (STEP)
Semaglutide is one of the most extensively studied GLP-1 receptor agonists:
Weight reduction: STEP studies reported mean weight loss of approximately 15% to 17% in adults with overweight or obesity.
Cardiovascular risk: Clinical data reported a 20% reduction in major adverse cardiovascular events.
Glycemic control: It improves blood-glucose control and stimulates glucose-dependent insulin secretion.
* Sold for laboratory research and in vitro models only. The information above summarizes findings reported in published medical literature and human clinical studies.
Frequently asked questions will be added before launch.
